Close
Nordic 9Nordic 9

Amboy Street Ventures (investor - None)

United States amboystreet.vc
See something wrong or missing? Let us know
Offices:Los Angeles

Amboy Street Ventures is an American venture capital fund focused on Women's Health & Sexual Wellbeing for all genders.

Average round investment:16.83M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)
Portfolio companies: Sweden Gesynta PharmaSwitzerland Testmate Health
Mostly invests in: Sweden Sweden (1) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Amboy Street Ventures

Name Criteria
Switzerland Lichtsteiner Foundation
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Linc Invest
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Broadview Ventures
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Germany Zeiss
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany DvH Ventures
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
Italy Angelini Ventures
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Ferd Capital
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United States Initialized Capital
90%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom Sweet Capital
89%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top